The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the recall on Dec. 13 and announced three days later that it was recalling the chips due to a potential or undeclared allergen. At present, no allergic reactions have been reported.
A major chocolate recall has been upgraded to the highest possible risk level.
The Food and Drug Administration has upgraded a December recall of Classic Lays Potato Chips to Class 1, the highest priority designated by the agency.
The FDA issued a product recall on Lay's Classic Potato Chips in two states. The recall was upgraded to the highest risk factor over undeclared milk.
The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.
Frito-Lay is recalling bags of Lay’s Classic Potato Chips after the FDA increased the risk level of the product to its highest level of risk classification.
Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall classification because the chocolates contained undeclared milk
Lay’s voluntary recall from December has been increased to the U.S. Food and Drug Administration’s highest risk level classification. On Dec. 13, Frito-Lay recalled more than 6,000 bags of 13 oz. Lay’s Classic Potato Chips due to “undeclared milk.” The affected chips were sold in Oregon and Washington.
Frito-Lay has recalled over 6,000 bags of Lay’s Classic Potato Chips due to undeclared milk, which poses a serious risk to individuals with dairy allergies. The FDA upgraded the recall to Class I—the highest risk level—after determining the chips could cause life-threatening allergic reactions,
The FDA has issued a Class I recall for Lay’s Classic Potato Chips due to undeclared milk, warning of severe allergic reactions or death.
Those with an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume the recalled product,” the FDA said in its initial notice on Dec. 16.